POLY MEDICURE Financial Statement Analysis
|
||
|
The Revenues of POLY MEDICURE have increased by 20.82% YoY .
The Earnings Per Share (EPS) of POLY MEDICURE has increased by 43.98 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
POLY MEDICURE Last 5 Annual Financial Results
[BOM: 531768|NSE : POLYMED]
| Consolidated | Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 |
|---|---|---|---|---|---|
| Revenues | ₹1,115 Cr | ₹923 Cr | ₹786 Cr | ₹687 Cr | ₹611 Cr |
| Expenses | ₹848 Cr | ₹708 Cr | ₹570 Cr | ₹521 Cr | ₹480 Cr |
| Operating Profit (Excl OI) | ₹267 Cr | ₹215 Cr | ₹216 Cr | ₹166 Cr | ₹131 Cr |
| Other Income | ₹36 Cr | ₹38 Cr | ₹18 Cr | ₹18 Cr | ₹18 Cr |
| Interest | ₹11 Cr | ₹6.16 Cr | ₹11 Cr | ₹20 Cr | ₹14 Cr |
| Depreciation | ₹57 Cr | ₹54 Cr | ₹48 Cr | ₹41 Cr | ₹37 Cr |
| Profit Before Tax | ₹237 Cr | ₹195 Cr | ₹180 Cr | ₹126 Cr | ₹100 Cr |
| Profit After Tax | ₹179 Cr | ₹147 Cr | ₹136 Cr | ₹96 Cr | ₹65 Cr |
| Consolidated Net Profit | ₹179 Cr | ₹147 Cr | ₹136 Cr | ₹96 Cr | ₹65 Cr |
| Earnings Per Share (Rs) | ₹26.91 | ₹18.69 | ₹15.28 | ₹14.17 | ₹10.86 |
| PAT Margin (%) | 18.70 | 16.01 | 15.80 | 17.19 | 13.89 |
| ROE(%) | 19.09 | 15.42 | 14.29 | 19.42 | 23.51 |
| ROCE(%) | 23.63 | 19.10 | 17.42 | 21.96 | 24.80 |
| Total Debt/Equity(x) | 0.12 | 0.12 | 0.12 | 0.14 | 0.47 |
Key Financials |
||
| Market Cap | : | ₹ 26,315.2 Cr |
| Revenue (TTM) | : | ₹ 1,522.5 Cr |
| Net Profit(TTM) | : | ₹ 292.7 Cr |
| EPS (TTM) | : | ₹ 28.9 |
| P/E (TTM) | : | 89.9 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| POLY MEDICURE | -8.9% | 0.3% | 74.6% |
| PREVEST DENPRO | -5.5% | 5.9% | 37.7% |
| NURECA | -2.5% | 2.5% | -22.9% |
POLY MEDICURE Revenues
[BOM: 531768|NSE : POLYMED]
| Y-o-Y | 20.82 % |
| 5 Yr CAGR | 16.24 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2024 | ₹1,115 Cr | 20.82 | |
| Mar2023 | ₹923 Cr | 17.37 | |
| Mar2022 | ₹786 Cr | 14.44 | |
| Mar2021 | ₹687 Cr | 12.51 | |
| Mar2020 | ₹611 Cr | - | |
POLY MEDICURE Operating Profit
[BOM: 531768|NSE : POLYMED]
| Y-o-Y | 24.37 % |
| 5 Yr CAGR | 19.48 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2024 | ₹267 Cr | 24.37 | |
| Mar2023 | ₹215 Cr | -0.68 | |
| Mar2022 | ₹216 Cr | 30.32 | |
| Mar2021 | ₹166 Cr | 26.59 | |
| Mar2020 | ₹131 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 2.96 % |
| 5 Yr CAGR | 2.79 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2024 | 23.98% | 2.96 | |
| Mar2023 | 23.29% | -15.40 | |
| Mar2022 | 27.53% | 13.90 | |
| Mar2021 | 24.17% | 12.52 | |
| Mar2020 | 21.48% | - | |
POLY MEDICURE Profit After Tax
[BOM: 531768|NSE : POLYMED]
| Y-o-Y | 22.37 % |
| 5 Yr CAGR | 28.67 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2024 | ₹179 Cr | 22.37 | |
| Mar2023 | ₹147 Cr | 7.82 | |
| Mar2022 | ₹136 Cr | 41.72 | |
| Mar2021 | ₹96 Cr | 46.60 | |
| Mar2020 | ₹65 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 16.80 % |
| 5 Yr CAGR | 7.72 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2024 | 18.7 % | 16.80 | |
| Mar2023 | 16.01 % | 1.33 | |
| Mar2022 | 15.8 % | -8.09 | |
| Mar2021 | 17.19 % | 23.76 | |
| Mar2020 | 13.89 % | - | |
POLY MEDICURE Earnings Per Share (EPS)
[BOM: 531768|NSE : POLYMED]
| Y-o-Y | 43.98 % |
| 5 Yr CAGR | 25.46 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2024 | ₹27 | 43.98 | |
| Mar2023 | ₹19 | 22.32 | |
| Mar2022 | ₹15 | 7.83 | |
| Mar2021 | ₹14 | 30.48 | |
| Mar2020 | ₹11 | - | |
POLY MEDICURE Return on Capital Employed (ROCE)
[BOM: 531768|NSE : POLYMED]
| Y-o-Y | 23.72 % |
| 5 Yr CAGR | -1.20 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2024 | 23.63% | 23.72 | |
| Mar2023 | 19.1% | 9.64 | |
| Mar2022 | 17.42% | -20.67 | |
| Mar2021 | 21.96% | -11.45 | |
| Mar2020 | 24.8% | - | |
POLY MEDICURE Share Price vs Sensex
| Current Share Price | : | ₹2,597.8 |
| Current MarketCap | : | ₹ 26,315.2 Cr |
| Updated EOD on | : | Dec 20,2024 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| POLY MEDICURE | -8.9% |
0.3% |
74.6% |
| SENSEX | -5% |
0.6% |
9.2% |
POLY MEDICURE related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| S&P BSE HEALTHCARE | 0.1% | 4% | 45% |
| S&P BSE ALLCAP | -0.3% | -3.5% | 35.8% |
| S&P BSE SMALL CAP | -3.2% | 5.1% | 31.1% |
| S&P BSE MIDSMALLCAP | -3.2% | 4.4% | 29.5% |
| S&P BSE 400 MIDSMALLCAP | -3.5% | 3.6% | 26.5% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY SMALLCAP250 | -3.1% | 5% | 28% |
| NIFTY MID SMALL400 | -3.2% | 4.3% | 26% |
| NIFTY500 MULTICAP 50:25:25 | -4.1% | 2.4% | 19.8% |
| NIFTY 500 | -4.5% | 1.4% | 16.6% |
You may also like the below Video Courses
FAQ about POLY MEDICURE Financials
How the annual revenues of POLY MEDICURE have changed ?
The Revenues of POLY MEDICURE have increased by 20.82% YoY .
How the Earnings per Share (EPS) of POLY MEDICURE have changed?
The Earnings Per Share (EPS) of POLY MEDICURE has increased by 43.98 % YoY .
Check out Intrinsic Value of Peers of POLY MEDICURE
|
Intrinsic Value of POLY MEDICURE LTD Intrinsic Value of PREVEST DENPRO LTD Intrinsic Value of NURECA LTD |
Compare Stock Analytics of Peers of POLY MEDICURE
POLY MEDICURE LTD vs PREVEST DENPRO LTD vs NURECA LTD
POLY MEDICURE LTD vs PREVEST DENPRO LTD vs NURECA LTD
